Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

29
Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
29
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

16
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
16
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

25
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
25
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

31
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
31
Mitral Stenosis IV: Nursing Management01:27

Mitral Stenosis IV: Nursing Management

22
A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
22
Mitral Regurgitation IV: Nursing Management01:28

Mitral Regurgitation IV: Nursing Management

68
Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...
68

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Regional travel distance is not associated with operative mortality in acute type A aortic dissection.

JTCVS open·2026
Same author

Embracing innovation and advancing care: integrating learning health system principles into Inova Schar Heart and Vascular.

Frontiers in cardiovascular medicine·2024
Same author

Center case volume is associated with Society of Thoracic Surgeons-defined failure to rescue in cardiac surgery.

The Journal of thoracic and cardiovascular surgery·2023
Same author

The Importance of Professional Advocacy-A Responsibility of ALL Cardiothoracic Surgeons.

The Annals of thoracic surgery·2022
Same author

COVID-19 Patients on Extracorporeal Membrane Oxygenation Did Not Experience Increased Prevalence of Intracranial Hemorrhage.

Critical care medicine·2022
Same author

Surgical strategy and outcomes for atrial functional mitral regurgitation: All functional mitral regurgitation is not the same!

The Journal of thoracic and cardiovascular surgery·2022

Related Experiment Video

Updated: Aug 11, 2025

A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair
08:31

A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair

Published on: October 16, 2021

4.0K

Pulmonary Hypertension and Operative Risk in Mitral Valve and Coronary Surgery.

Robert B Hawkins1, Raymond J Strobel2, J Hunter Mehaffey2

  • 1Department of Cardiac Surgery, University of Michigan, Ann Arbor, Michigan.

The Journal of Surgical Research
|February 8, 2023
PubMed
Summary

Pulmonary hypertension (PHT) poses a lower risk for mitral valve surgery than for coronary artery bypass grafting (CABG). This finding highlights the need for optimized perioperative care for PHT patients undergoing cardiac procedures.

Keywords:
Mitral valveOutcomes researchPulmonary hypertensionResource utilization

More Related Videos

Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels
08:12

Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels

Published on: May 26, 2023

1.7K
An Image Guided Transapical Mitral Valve Leaflet Puncture Model of Controlled Volume Overload from Mitral Regurgitation in the Rat
07:42

An Image Guided Transapical Mitral Valve Leaflet Puncture Model of Controlled Volume Overload from Mitral Regurgitation in the Rat

Published on: May 19, 2020

7.1K

Related Experiment Videos

Last Updated: Aug 11, 2025

A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair
08:31

A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair

Published on: October 16, 2021

4.0K
Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels
08:12

Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels

Published on: May 26, 2023

1.7K
An Image Guided Transapical Mitral Valve Leaflet Puncture Model of Controlled Volume Overload from Mitral Regurgitation in the Rat
07:42

An Image Guided Transapical Mitral Valve Leaflet Puncture Model of Controlled Volume Overload from Mitral Regurgitation in the Rat

Published on: May 19, 2020

7.1K

Area of Science:

  • Cardiology
  • Cardiac Surgery
  • Pulmonary Hypertension

Background:

  • Pulmonary hypertension (PHT) is a known risk factor for coronary artery bypass grafting (CABG).
  • The impact of PHT on outcomes following mitral valve operations is less understood.
  • This study investigates the association between PHT and surgical risk in mitral valve operations compared to CABG.

Purpose of the Study:

  • To test the hypothesis that PHT is associated with a lower risk during mitral valve operations compared to CABG.
  • To analyze the association of pulmonary artery systolic pressure (PASP) with operative outcomes in patients undergoing mitral valve or CABG procedures.
  • To identify potential differences in risk stratification for patients with PHT undergoing different cardiac surgeries.

Main Methods:

  • Utilized data from a regional Society of Thoracic Surgeons (STS) database (2011-2019).
  • Included patients undergoing isolated mitral valve or CABG operations.
  • Stratified patients by pulmonary artery systolic pressure (PASP) and used hierarchical regression modeling, adjusting for STS predicted risk scores.

Main Results:

  • Mitral valve surgery patients had higher mean STS risk of mortality and median PASP compared to CABG patients.
  • Increased PASP was independently associated with operative mortality and major morbidity in both groups.
  • A 10-mmHg increase in PASP was associated with lower odds of morbidity, mortality, and ICU time in mitral patients compared to CABG patients (P < 0.0001).

Conclusions:

  • Despite higher preoperative pulmonary artery pressures, PHT was linked to lower risk for mitral valve surgery outcomes compared to CABG.
  • Further research is needed to optimize perioperative management of patients with PHT.
  • Improved understanding and care strategies for PHT patients undergoing cardiac surgery are essential.